Biorasi is a leading global Contract Research Organization (CRO) that specializes in accelerating clinical trials. With a focus on speed and agility, Biorasi's award-winning team delivers comprehensive solutions in the healthcare technology, pharmaceuticals, and healthcare services industries, ensuring successful trial outcomes for clients worldwide.
Specialties
Accelerated clinical trial management
Global contract research organization
Healthcare technology expertise
Pharmaceutical trial acceleration
Unconventional clinical research strategies
Products & Services
Clinical Trial Management
Regulatory Affairs Support
Data Management Services
Clinical Monitoring
Patient Recruitment Solutions
Contact Information
No contact information available
Competitors & Similar Companies(7)
IQVIA
Connecticut, • United States
Parexel
Massachusetts, • United States
Covance
New Jersey, • United States
Medpace
Ohio, • United States
PPD (Pharmaceutical Product Development)
North Carolina, • United States
Syneos Health
North Carolina, • United States
WuXi AppTec
Shanghai, • China
News & Media
Search Terms:
biorasi
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Loading...
Frequently Asked Questions about Biorasi
Where is Biorasi located?
The headquarter of Biorasi is located in Aventura, Florida, United States
Competitors of Biorasi are IQVIA, Parexel, Covance, Medpace, PPD (Pharmaceutical Product Development), Syneos Health, WuXi AppTec.
What does Biorasi do?
Biorasi is a leading global Contract Research Organization (CRO) that specializes in accelerating clinical trials. With a focus on speed and agility, Biorasi's award-winning team delivers comprehensive solutions in the healthcare technology, pharmaceuticals, and healthcare services industries, ensuring successful trial outcomes for clients worldwide.